Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy

• Consider immune dysfunction in rapidly progressing soft tissue infections refractory to medical or surgical management. • Vulvar ulcers may rapidly progress to severe complications in patients with immune dysfunction after CAR T-cell therapy. • As CAR T-cell therapy use expands, recognition of uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotangco, Katherine, Manrriquez, Erica N., Salani, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194578/
https://www.ncbi.nlm.nih.gov/pubmed/35711731
http://dx.doi.org/10.1016/j.gore.2022.101016
_version_ 1784726761063317504
author Cotangco, Katherine
Manrriquez, Erica N.
Salani, Ritu
author_facet Cotangco, Katherine
Manrriquez, Erica N.
Salani, Ritu
author_sort Cotangco, Katherine
collection PubMed
description • Consider immune dysfunction in rapidly progressing soft tissue infections refractory to medical or surgical management. • Vulvar ulcers may rapidly progress to severe complications in patients with immune dysfunction after CAR T-cell therapy. • As CAR T-cell therapy use expands, recognition of unique toxicities is an important consideration.
format Online
Article
Text
id pubmed-9194578
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91945782022-06-15 Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy Cotangco, Katherine Manrriquez, Erica N. Salani, Ritu Gynecol Oncol Rep Case Report • Consider immune dysfunction in rapidly progressing soft tissue infections refractory to medical or surgical management. • Vulvar ulcers may rapidly progress to severe complications in patients with immune dysfunction after CAR T-cell therapy. • As CAR T-cell therapy use expands, recognition of unique toxicities is an important consideration. Elsevier 2022-05-31 /pmc/articles/PMC9194578/ /pubmed/35711731 http://dx.doi.org/10.1016/j.gore.2022.101016 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Cotangco, Katherine
Manrriquez, Erica N.
Salani, Ritu
Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy
title Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy
title_full Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy
title_fullStr Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy
title_full_unstemmed Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy
title_short Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy
title_sort rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following car t-cell therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194578/
https://www.ncbi.nlm.nih.gov/pubmed/35711731
http://dx.doi.org/10.1016/j.gore.2022.101016
work_keys_str_mv AT cotangcokatherine rapidlyprogressingvulvarsofttissueinfectionasaresultofseverehypogammaglobulinemiafollowingcartcelltherapy
AT manrriquezerican rapidlyprogressingvulvarsofttissueinfectionasaresultofseverehypogammaglobulinemiafollowingcartcelltherapy
AT salaniritu rapidlyprogressingvulvarsofttissueinfectionasaresultofseverehypogammaglobulinemiafollowingcartcelltherapy

Ejemplares similares